Both in Pharmaceuticals
Oramed Pharmaceuticals vs ALX Oncology Holdings
Over the past year ORMP returned +71.3% and ALXO returned −21.3%; their daily moves had a correlation of 0.05.
ORMP +71.3% ALXO −21.3%Growth of $1, one year, split-adjusted
| Metric | ORMP | ALXO |
|---|---|---|
| Price | $4.11 | $1.22 |
| Market cap | $171.0M | $168.7M |
| Today | −2.84% | 0.00% |
| 1 month | −8.3% | −6.2% |
| 6 months | +3.3% | −27.8% |
| Year to date | +44.2% | +8.0% |
| 1 year | +73.4% | −23.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 1.0× | — |
| Price / sales | — | — |
| Net cash | $50.6M | $128.5M |
| Dividend yield | 6.08% | — |
| Volatility (60d) | 35.8% | 88.9% |
| Short % of float | 4.3% | 6.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).